$INBS

$1.64 +$0.05 (3.14%) Close

$INBS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 3.0M shares outstanding

Who owns INBS?

By type of holder

Institutions 6.0% Insiders 3.0% Everyone else 91.0%

Concentration Top 10 holders own 8.8%

Armistice Capital, LLC 4.7% · Sakiris Spiro Kevin 1.2%

Institutional ownership

6.0%

-0.9 pts vs last qtr

Institutional holders

-1 vs last qtr

Net shares bought

−27.0K

by institutions in Q2 2026

New / sold out

1 / 2

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Armistice Capital, LLC +11.4K
UBS Group AG +5.4K

Biggest sellers in Q2 2026

Alyeska Investment Group, L.P. SOLD OUT −38.0K
Geode Capital Management, LLC −7.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Intelligent Bio Solutions Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2026

+1105.1%

+86.32% a year

Each share's claim on the business

−91.7%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $924K

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

15.6%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting INBS on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AC Armistice Capital, LLC	141.4K	4.67%	+11.4K (+8.8%)	Q1 '26	0.0%
Shares held by quarter Peak holding141.4K (Q2'26) Change over 8 quarters+141.4K Share of the company4.670% Armistice Capital, LLC's full portfolio →
AI Alyeska Investment Group, L.P.	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding38.0K (Q1'26) Change over 8 quarters0 Alyeska Investment Group, L.P.'s full portfolio →

Armistice Capital, LLC

141.4K

% of company

4.67%

Change vs last qtr

+11.4K (+8.8%)

Held since

Q1 '26

Alyeska Investment Group, L.P.

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

8 more super investors behind a free account

See every manager holding Intelligent Bio Solutions Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting INBS on Form N-PORT; together they hold 0.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$29.9K	12.5K	0.41%	0.00%	August 31, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$13.3K	5.8K	0.19%	0.00%	June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$29.9K

% of company

0.41%

% of the fund

0.00%

As of

August 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$13.3K

% of company

0.19%

% of the fund

0.00%

As of

June 30, 2026

4 more funds behind a free account

See every fund holding Intelligent Bio Solutions Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SS Sakiris Spiro Kevin Insider	36.7K	1.21%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.210% Sakiris Spiro Kevin's insider activity →
SH Simeonidis Harry Insider	34.5K	1.14%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.140% Simeonidis Harry's insider activity →

Sakiris Spiro Kevin

Insider

36.7K

% of company

1.21%

Change vs last qtr

—

Held since

—

Simeonidis Harry

Insider

34.5K

% of company

1.14%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Intelligent Bio Solutions Inc.

Comments